3042B |
Metolazone, Blood |
3042SP |
Metolazone, Serum/Plasma |
3043B |
Metoprolol, Blood |
3043FL |
Metoprolol, Fluid |
3043SP |
Metoprolol, Serum/Plasma |
3043U |
Metoprolol, Urine |
3103B |
Nadolol, Blood |
3103SP |
Nadolol, Serum/Plasma |
3103U |
Nadolol, Urine |
3157U |
Cotinine and Anabasine from Secondary Exposure, Urine |
3158B |
Nifedipine, Blood |
3158SP |
Nifedipine, Serum/Plasma |
3174B |
Nitrate/Nitrite (Qualitative), Blood (Forensic) |
3174SP |
Nitrate/Nitrite (Qualitative), Serum/Plasma |
3225SP |
Nuedexta®, Serum/Plasma |
3250SP |
Oxalate, Serum/Plasma |
3300B |
Papaverine, Blood |
3300SP |
Papaverine, Serum/Plasma |
3426B |
Perfluorooctanoic Acid, Blood Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3427SP |
Perfluoroalkyl Substances (PFAS), Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3428SP |
PFASure TM, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3429SP |
PFASure TM Expanded, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3788B |
Prazosin, Blood |
3788SP |
Prazosin, Serum/Plasma |